Release Date: 03/12/12 16:44 Summary: Company Secretary Appointment/Resignation Price Sensitive: No Download Document 2.94MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%